Filtros de búsqueda

Lista de obras de Luís Lima

Abnormal Protein Glycosylation and Activated PI3K/Akt/mTOR Pathway: Role in Bladder Cancer Prognosis and Targeted Therapeutics.

artículo científico publicado en 2015

Association between FAS polymorphism and prostate cancer development

article

CD44 glycoprotein in cancer: a molecular conundrum hampering clinical applications.

artículo científico publicado en 2018

CIS is a surrogate marker of genetic instability and field carcinogenesis in the urothelial mucosa.

artículo científico publicado en 2009

Circulating tumor cells in bladder cancer: Emerging technologies and clinical implications foreseeing precision oncology.

artículo científico publicado en 2018

Common genetic polymorphisms in the ABCB1 gene are associated with risk of major depressive disorder in male Portuguese individuals.

artículo científico publicado en 2013

FAS -670A>G genetic polymorphism Is associated with Treatment Resistant Depression.

artículo científico publicado en 2015

FASL polymorphism is associated with response to bacillus Calmette-Guérin immunotherapy in bladder cancer.

artículo científico publicado en 2013

Glycan affinity magnetic nanoplatforms for urinary glycobiomarkers discovery in bladder cancer.

artículo científico publicado en 2018

Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion

artículo científico publicado en 2022

Hypoxia enhances the malignant nature of bladder cancer cells and concomitantly antagonizes protein O-glycosylation extension

artículo científico publicado en 2016

IL-4 and TNF-α Polymorphisms Are Associated with Risk of Multiple Superficial Tumors or Carcinoma in situ Development

article

IL6-174G > C genetic polymorphism influences antidepressant treatment outcome

artículo científico publicado en 2016

Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2-6 sialic acids

artículo científico publicado en 2018

Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?

artículo científico publicado en 2017

P53 and cancer-associated sialylated glycans are surrogate markers of cancerization of the bladder associated with Schistosoma haematobium infection.

artículo científico publicado en 2014

Predictive biomarkers of bacillus calmette-guérin immunotherapy response in bladder cancer: where are we now?

artículo científico publicado en 2012

Reference Genes for Addressing Gene Expression of Bladder Cancer Cell Models under Hypoxia: A Step Towards Transcriptomic Studies

artículo científico publicado en 2016

Response of high-risk of recurrence/progression bladder tumours expressing sialyl-Tn and sialyl-6-T to BCG immunotherapy

artículo científico publicado en 2013

Syndecan-4 is a maestro of gastric cancer cell invasion and communication that underscores poor survival

scientific article published in 2023

TERT Promoter Mutation as a Potential Predictive Biomarker in BCG-Treated Bladder Cancer Patients

artículo científico publicado en 2020

Targeted O-glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced-stage bladder tumours

artículo científico publicado en 2017

The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure.

artículo científico publicado en 2013

The role of IL18-607C>A and IL18-137G>C promoter polymorphisms in antidepressant treatment phenotypes: A preliminary report.

artículo científico publicado en 2016

The role of functional polymorphisms in immune response genes as biomarkers of bacille Calmette-Guérin (BCG) immunotherapy outcome in bladder cancer: establishment of a predictive profile in a Southern Europe population

artículo científico publicado en 2015

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda